Downloads
Abstract
Background: Patients with cancer often have to use drug for along time, so herbal products supportting treatment are increasingly being used. Objective: To evaluate the effectiveness and safety of Curminol-K in the support of cancer treatment. Methods: 79 patients diagnosed with cancer and treated at Oncology Center - Thai Nguyen National Hospital. Interventional and prospective method was used. Results: After treatment, the clinical symptoms including anorexia, thinness, bloating, indigestion, fatigue, blue skin, nausea and vomiting all improved; Test results to assess liver, kidney function and hematological indicators at the time of T0, T3, T6 did not change between the two groups and were within normal limits; The majority of patients were fairly and well tolerated (82,5%). Conclusion: Curminol-K was clinically evaluated for effectiveness and safety, so it needs to be further and longitudinally studied with a larger sample and longer follow-up time to confirm its effectiveness and safety in supporting cancer treatment.
| Published | 2023-03-23 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | Vol. 2 No. 1 (2023) | |
| Section | Original article | |
| DOI | ||
| Keywords | Điều trị ung thư, Curcumin, Polyphenol Cancer treatment, Curcumin, Polyphenol |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Journal of Science and Technology in Medicine and Pharmacy
Trần Văn Thuấn, Bùi Diệu, Nguyễn Bá Đức và cộng sự. Gánh nặng bệnh ung thư và chiến lược phòng chống ung thư quốc gia đến năm 2020. Tạp chí Ung thư học - Hội thảo quốc gia phòng chống ung thư lần thứ 16 tháng 10 năm 2012, Số 1, (2012)
Dương Thị Hồng Ánh. “Nghiên cứu bào chế hệ tiểu phân nano nhằm tăng sinh khả dụng của curcumin dùng theo đường uống”, Luận án tiến sĩ dược học, Trường đại học dược Hà Nội, (2017).
Mai Thanh Nga. “Góp phần nghiên cứu thành phần hóa học,tách chiết hợp chất polyphenol trong cây chè xanh thái nguyên”, Tạp chí Khoa học và công nghệ, Tập 80 (04), Trang 159-161, (2011).
Francesca M. et al. Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cells mediated immune response. Frontiers in oncology., vol 3, art 137, 1-11, (2013).
Arshad et al. Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways. Biomed Res Int.; Sep 10, 2014:761608, (2014).
Murali M.Y. et al. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cells growth. J Ovar Res, pp.3-11, (2010).
Mhd Aas Tomeh. A Review of Curcumin and Its Derivatives as Anticancer Agents. Int J Mol Sci. Feb 27; 20 (5), 1033, (2019).
Liu J. et al. Recent progress in studying curcumin and its nano-preparations for cancer therapy. Cur Pharm Des, 19(11), 1974-93, (2013). 9. Saghatelyan T. et.al, Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. Apr 18;70:153218. doi: 10.1016 (2020).
Murali M. Y. et al. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Disc Today, vol 17, No 1/2, 71-80. (2012).
Howells LM et al (2019). Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial. J Nutr. Jul 1;149(7):1133-1139, (2019), doi: 10.1093.